Ashland Specialty Ingredients, a commercial unit of Ashland Inc., has opened a pharmaceutical center of excellence in Wilmington, Delaware. The new facility will focus on drug development and bioavailability enhancement and expands Ashland’s global network of pharmaceutical research and development centers. The facility also offers formulation and contract development for solid dispersions and oral solid-dosage forms. To support early-stage proof-of concept-studies, capabilities include spray drying, hot-melt extrusion, and potent-compound processing suites.

This center of excellence expands Ashland’s global network of R&D and technical support facilities dedicated to the advancement of consumer products. It follows the opening of a pharmaceutical center of excellence in Hyderabad, India, earlier this year and a personal care center of excellence in Mumbai, India, in 2012. Ashland Specialty Ingredients has 10 centers of excellence around the world.

Source: Ashland Specialty Ingredients